Coherus BioSciences, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 11/18/2020   Download
SEC Document
SEC Filing

On and effective as of November 12, 2020, the Board amended and restated the Company’s amended and restated bylaws (as further amended and restated, the “Amended and Restated Bylaws”) to amend Article VII to provide that unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, to the fullest extent permitted by law (the “Amendment”).